Measuring what matters to patients: Systematic literature review of patient-reported outcomes assessment and reporting in locally advanced or metastatic urothelial cancer real-world and clinical studies
PROs can assist in the tailoring of treatment strategies to improve outcomes and can aid in enhancing communication between patients and healthcare professionals about treatment choice. Our evaluation of PRO reporting quality identified room for improvement in most studies, indicating a need for robust, consistent reporting of PRO data to adequately capture the experiences of patients with la/mUC.
Authors
- T. M. McMillan (ORCID: https://orcid.org/0000-0002-5278-9889)
- Julia Poritz
- Mihaela Georgiana Musat (ORCID: https://orcid.org/0000-0001-5575-3809)
- Mairead Kearney
- Sherrie Schreiber-Gosche
Institutions
- Cytel (United States) (US)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1016/j.urolonc.2025.09.016
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00